APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Pain Medication

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Veterinary Pain Medication Market Outlook and Growth Opportunities 2026

21 December 2025200 pages

Choose your research edition.

Industry ResearchVeterinary Pain Medication Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Pain Medication Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Veterinary Pain Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Pain Medication Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Pain Medication Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Veterinary Pain Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Veterinary Pain Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Pain Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Pain Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Veterinary Pain Medication market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Veterinary Pain Medication market include Zoetis, Ringpu Bio-technology, Ruicheng Lvman Biological Pharmaceutical Co., Ltd., Merck & Co, Medtronic, Lilly, Pfizer, Harbin Bolai Pharmaceutical Co., Ltd. and Bostonscientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Veterinary Pain Medication market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Pain Medication and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Pain Medication sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Pain Medication market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Pain Medication Segment by Company

Zoetis

Ringpu Bio-technology

Ruicheng Lvman Biological Pharmaceutical Co., Ltd.

Merck & Co

Medtronic

Lilly

Pfizer

Harbin Bolai Pharmaceutical Co., Ltd.

Bostonscientific

Bayer Pharma AG

Baxter

Norbrook Laboratories

Halyard

Forest Laboratories

Endo International

Elanco

Ceva Sante Animale

Boehringer Ingelheim

Veterinary Pain Medication Segment by Type

Injection Medicines

Oral Medicines

Veterinary Pain Medication Segment by Application

Veterinary Hospitals

Veterinary Clinics

Others

Veterinary Pain Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Veterinary Pain Medication status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Veterinary Pain Medication market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary Pain Medication significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary Pain Medication competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Pain Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Pain Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Pain Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Pain Medication market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Pain Medication industry.

Chapter 3: Detailed analysis of Veterinary Pain Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Veterinary Pain Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Veterinary Pain Medication in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary Pain Medication Industry Trends Table 2. Veterinary Pain Medication Industry Drivers Table 3. Veterinary Pain Medication Industry Opportunities and Challenges Table 4. Veterinary Pain Medication Industry Restraints Table 5. Global Veterinary Pain Medication Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary Pain Medication Revenue Share by Company (2021-2026) Table 7. Global Veterinary Pain Medication Sales Volume by Company (k units) & (2021-2026) Table 8. Global Veterinary Pain Medication Sales Volume Share by Company (2021-2026) Table 9. Global Veterinary Pain Medication Average Price (US$/unit) of Company (2021-2026) Table 10. Global Veterinary Pain Medication Company Ranking, (2024-2026) & (USD Million) Table 11. Global Veterinary Pain Medication Key Company Manufacturing Base & Headquarters Table 12. Global Veterinary Pain Medication Company, Product Type & Application Table 13. Global Veterinary Pain Medication Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary Pain Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Medicines Table 18. Significant Companies of Oral Medicines Table 19. Global Veterinary Pain Medication Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Veterinary Pain Medication Sales Volume by Type (2021-2026) & (k units) Table 21. Global Veterinary Pain Medication Sales Volume by Type (2027-2032) & (k units) Table 22. Global Veterinary Pain Medication Sales Volume Share by Type (2021-2026) Table 23. Global Veterinary Pain Medication Sales Volume Share by Type (2027-2032) Table 24. Global Veterinary Pain Medication Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Veterinary Pain Medication Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Veterinary Pain Medication Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Veterinary Pain Medication Sales Value Share by Type (2021-2026) Table 28. Global Veterinary Pain Medication Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Veterinary Hospitals Table 30. Significant Companies of Veterinary Clinics Table 31. Significant Companies of Others Table 32. Global Veterinary Pain Medication Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Veterinary Pain Medication Sales Volume by Application (2021-2026) & (k units) Table 34. Global Veterinary Pain Medication Sales Volume by Application (2027-2032) & (k units) Table 35. Global Veterinary Pain Medication Sales Volume Share by Application (2021-2026) Table 36. Global Veterinary Pain Medication Sales Volume Share by Application (2027-2032) Table 37. Global Veterinary Pain Medication Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Veterinary Pain Medication Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Veterinary Pain Medication Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Veterinary Pain Medication Sales Value Share by Application (2021-2026) Table 41. Global Veterinary Pain Medication Sales Value Share by Application (2027-2032) Table 42. Global Veterinary Pain Medication Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Veterinary Pain Medication Sales by Region (2021-2026) & (k units) Table 44. Global Veterinary Pain Medication Sales Market Share by Region (2021-2026) Table 45. Global Veterinary Pain Medication Sales by Region (2027-2032) & (k units) Table 46. Global Veterinary Pain Medication Sales Market Share by Region (2027-2032) Table 47. Global Veterinary Pain Medication Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Veterinary Pain Medication Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Veterinary Pain Medication Sales Value Share by Region (2021-2026) Table 50. Global Veterinary Pain Medication Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Veterinary Pain Medication Sales Value Share by Region (2027-2032) Table 52. Global Veterinary Pain Medication Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Veterinary Pain Medication Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Veterinary Pain Medication Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Veterinary Pain Medication Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Veterinary Pain Medication Sales by Country (2021-2026) & (k units) Table 57. Global Veterinary Pain Medication Sales Market Share by Country (2021-2026) Table 58. Global Veterinary Pain Medication Sales by Country (2027-2032) & (k units) Table 59. Global Veterinary Pain Medication Sales Market Share by Country (2027-2032) Table 60. Global Veterinary Pain Medication Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Veterinary Pain Medication Sales Value Market Share by Country (2021-2026) Table 62. Global Veterinary Pain Medication Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Veterinary Pain Medication Sales Value Market Share by Country (2027-2032) Table 64. Zoetis Company Information Table 65. Zoetis Business Overview Table 66. Zoetis Veterinary Pain Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Zoetis Veterinary Pain Medication Product Portfolio Table 68. Zoetis Recent Development Table 69. Ringpu Bio-technology Company Information Table 70. Ringpu Bio-technology Business Overview Table 71. Ringpu Bio-technology Veterinary Pain Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Ringpu Bio-technology Veterinary Pain Medication Product Portfolio Table 73. Ringpu Bio-technology Recent Development Table 74. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Company Information Table 75. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Business Overview Table 76. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolio Table 78. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Recent Development Table 79. Merck & Co Company Information Table 80. Merck & Co Business Overview Table 81. Merck & Co Veterinary Pain Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Merck & Co Veterinary Pain Medication Product Portfolio Table 83. Merck & Co Recent Development Table 84. Medtronic Company Information Table 85. Medtronic Business Overview Table 86. Medtronic Veterinary Pain Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Medtronic Veterinary Pain Medication Product Portfolio Table 88. Medtronic Recent Development Table 89. Lilly Company Information Table 90. Lilly Business Overview Table 91. Lilly Veterinary Pain Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Lilly Veterinary Pain Medication Product Portfolio Table 93. Lilly Recent Development Table 94. Pfizer Company Information Table 95. Pfizer Business Overview Table 96. Pfizer Veterinary Pain Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Pfizer Veterinary Pain Medication Product Portfolio Table 98. Pfizer Recent Development Table 99. Harbin Bolai Pharmaceutical Co., Ltd. Company Information Table 100. Harbin Bolai Pharmaceutical Co., Ltd. Business Overview Table 101. Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolio Table 103. Harbin Bolai Pharmaceutical Co., Ltd. Recent Development Table 104. Bostonscientific Company Information Table 105. Bostonscientific Business Overview Table 106. Bostonscientific Veterinary Pain Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Bostonscientific Veterinary Pain Medication Product Portfolio Table 108. Bostonscientific Recent Development Table 109. Bayer Pharma AG Company Information Table 110. Bayer Pharma AG Business Overview Table 111. Bayer Pharma AG Veterinary Pain Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Bayer Pharma AG Veterinary Pain Medication Product Portfolio Table 113. Bayer Pharma AG Recent Development Table 114. Baxter Company Information Table 115. Baxter Business Overview Table 116. Baxter Veterinary Pain Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Baxter Veterinary Pain Medication Product Portfolio Table 118. Baxter Recent Development Table 119. Norbrook Laboratories Company Information Table 120. Norbrook Laboratories Business Overview Table 121. Norbrook Laboratories Veterinary Pain Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Norbrook Laboratories Veterinary Pain Medication Product Portfolio Table 123. Norbrook Laboratories Recent Development Table 124. Halyard Company Information Table 125. Halyard Business Overview Table 126. Halyard Veterinary Pain Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Halyard Veterinary Pain Medication Product Portfolio Table 128. Halyard Recent Development Table 129. Forest Laboratories Company Information Table 130. Forest Laboratories Business Overview Table 131. Forest Laboratories Veterinary Pain Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Forest Laboratories Veterinary Pain Medication Product Portfolio Table 133. Forest Laboratories Recent Development Table 134. Endo International Company Information Table 135. Endo International Business Overview Table 136. Endo International Veterinary Pain Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Endo International Veterinary Pain Medication Product Portfolio Table 138. Endo International Recent Development Table 139. Elanco Company Information Table 140. Elanco Business Overview Table 141. Elanco Veterinary Pain Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 142. Elanco Veterinary Pain Medication Product Portfolio Table 143. Elanco Recent Development Table 144. Ceva Sante Animale Company Information Table 145. Ceva Sante Animale Business Overview Table 146. Ceva Sante Animale Veterinary Pain Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 147. Ceva Sante Animale Veterinary Pain Medication Product Portfolio Table 148. Ceva Sante Animale Recent Development Table 149. Boehringer Ingelheim Company Information Table 150. Boehringer Ingelheim Business Overview Table 151. Boehringer Ingelheim Veterinary Pain Medication Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 152. Boehringer Ingelheim Veterinary Pain Medication Product Portfolio Table 153. Boehringer Ingelheim Recent Development Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Veterinary Pain Medication Distributors List Table 157. Veterinary Pain Medication Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Veterinary Pain Medication Product Image Figure 2. Global Veterinary Pain Medication Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Pain Medication Sales Value (2021-2032) & (US$ Million) Figure 4. Global Veterinary Pain Medication Sales (2021-2032) & (k units) Figure 5. Global Veterinary Pain Medication Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Veterinary Pain Medication Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Medicines Image Figure 10. Oral Medicines Image Figure 11. Global Veterinary Pain Medication Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Veterinary Pain Medication Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Veterinary Pain Medication Sales Volume Share by Type (2021-2032) Figure 14. Global Veterinary Pain Medication Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Veterinary Pain Medication Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Veterinary Pain Medication Sales Value Share by Type (2021-2032) Figure 17. Veterinary Hospitals Image Figure 18. Veterinary Clinics Image Figure 19. Others Image Figure 20. Global Veterinary Pain Medication Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Veterinary Pain Medication Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Veterinary Pain Medication Sales Volume Share by Application (2021-2032) Figure 23. Global Veterinary Pain Medication Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Veterinary Pain Medication Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Veterinary Pain Medication Sales Value Share by Application (2021-2032) Figure 26. Global Veterinary Pain Medication Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Veterinary Pain Medication Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Veterinary Pain Medication Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Veterinary Pain Medication Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Veterinary Pain Medication Sales Value (2021-2032) & (US$ Million) Figure 31. North America Veterinary Pain Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Veterinary Pain Medication Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Veterinary Pain Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Veterinary Pain Medication Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Veterinary Pain Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Veterinary Pain Medication Sales Value (2021-2032) & (US$ Million) Figure 37. South America Veterinary Pain Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Veterinary Pain Medication Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Veterinary Pain Medication Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Veterinary Pain Medication Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Veterinary Pain Medication Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Veterinary Pain Medication Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Medicines
  • Oral Medicines
Applications
  • Veterinary Hospitals
  • Veterinary Clinics
  • Others
Companies covered
  • Zoetis
  • Ringpu Bio-technology
  • Ruicheng Lvman Biological Pharmaceutical Co., Ltd.
  • Merck & Co
  • Medtronic
  • Lilly
  • Pfizer
  • Harbin Bolai Pharmaceutical Co., Ltd.
  • Bostonscientific
  • Bayer Pharma AG
  • Baxter
  • Norbrook Laboratories
  • Halyard
  • Forest Laboratories
  • Endo International
  • Elanco
  • Ceva Sante Animale
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary Pain Medication Sales Value (2021-2032)
  4. 1.2.2 Global Veterinary Pain Medication Sales Volume (2021-2032)
  5. 1.2.3 Global Veterinary Pain Medication Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Veterinary Pain Medication Market Dynamics
  1. 2.1 Veterinary Pain Medication Industry Trends
  2. 2.2 Veterinary Pain Medication Industry Drivers
  3. 2.3 Veterinary Pain Medication Industry Opportunities and Challenges
  4. 2.4 Veterinary Pain Medication Industry Restraints
3 Veterinary Pain Medication Market by Company
  1. 3.1 Global Veterinary Pain Medication Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary Pain Medication Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary Pain Medication Sales Volume by Company (2021-2026)
  4. 3.4 Global Veterinary Pain Medication Average Price by Company (2021-2026)
  5. 3.5 Global Veterinary Pain Medication Company Ranking (2024-2026)
  6. 3.6 Global Veterinary Pain Medication Company Manufacturing Base and Headquarters
  7. 3.7 Global Veterinary Pain Medication Company Product Type and Application
  8. 3.8 Global Veterinary Pain Medication Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Veterinary Pain Medication Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Veterinary Pain Medication Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Veterinary Pain Medication Market by Type
  1. 4.1 Veterinary Pain Medication Type Introduction
  2. 4.1.1 Injection Medicines
  3. 4.1.2 Oral Medicines
  4. 4.2 Global Veterinary Pain Medication Sales Volume by Type
  5. 4.2.1 Global Veterinary Pain Medication Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Veterinary Pain Medication Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Veterinary Pain Medication Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Veterinary Pain Medication Sales Value by Type
  9. 4.3.1 Global Veterinary Pain Medication Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Veterinary Pain Medication Sales Value by Type (2021-2032)
  11. 4.3.3 Global Veterinary Pain Medication Sales Value Share by Type (2021-2032)
5 Veterinary Pain Medication Market by Application
  1. 5.1 Veterinary Pain Medication Application Introduction
  2. 5.1.1 Veterinary Hospitals
  3. 5.1.2 Veterinary Clinics
  4. 5.1.3 Others
  5. 5.2 Global Veterinary Pain Medication Sales Volume by Application
  6. 5.2.1 Global Veterinary Pain Medication Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Veterinary Pain Medication Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Veterinary Pain Medication Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Veterinary Pain Medication Sales Value by Application
  10. 5.3.1 Global Veterinary Pain Medication Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Veterinary Pain Medication Sales Value by Application (2021-2032)
  12. 5.3.3 Global Veterinary Pain Medication Sales Value Share by Application (2021-2032)
6 Veterinary Pain Medication Regional Sales and Value Analysis
  1. 6.1 Global Veterinary Pain Medication Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Pain Medication Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary Pain Medication Sales by Region: 2021-2026
  4. 6.2.2 Global Veterinary Pain Medication Sales by Region (2027-2032)
  5. 6.3 Global Veterinary Pain Medication Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Veterinary Pain Medication Sales Value by Region (2021-2032)
  7. 6.4.1 Global Veterinary Pain Medication Sales Value by Region: 2021-2026
  8. 6.4.2 Global Veterinary Pain Medication Sales Value by Region (2027-2032)
  9. 6.5 Global Veterinary Pain Medication Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Veterinary Pain Medication Sales Value (2021-2032)
  12. 6.6.2 North America Veterinary Pain Medication Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Veterinary Pain Medication Sales Value (2021-2032)
  15. 6.7.2 Europe Veterinary Pain Medication Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Veterinary Pain Medication Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Veterinary Pain Medication Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Veterinary Pain Medication Sales Value (2021-2032)
  21. 6.9.2 South America Veterinary Pain Medication Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Veterinary Pain Medication Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Veterinary Pain Medication Sales Value Share by Country, 2025 VS 2032
7 Veterinary Pain Medication Country-level Sales and Value Analysis
  1. 7.1 Global Veterinary Pain Medication Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary Pain Medication Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Veterinary Pain Medication Sales by Country (2021-2032)
  4. 7.3.1 Global Veterinary Pain Medication Sales by Country (2021-2026)
  5. 7.3.2 Global Veterinary Pain Medication Sales by Country (2027-2032)
  6. 7.4 Global Veterinary Pain Medication Sales Value by Country (2021-2032)
  7. 7.4.1 Global Veterinary Pain Medication Sales Value by Country (2021-2026)
  8. 7.4.2 Global Veterinary Pain Medication Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Veterinary Pain Medication Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Veterinary Pain Medication Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Veterinary Pain Medication Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Veterinary Pain Medication Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Veterinary Pain Medication Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Ringpu Bio-technology
  8. 8.2.1 Ringpu Bio-technology Company Information
  9. 8.2.2 Ringpu Bio-technology Business Overview
  10. 8.2.3 Ringpu Bio-technology Veterinary Pain Medication Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Ringpu Bio-technology Veterinary Pain Medication Product Portfolio
  12. 8.2.5 Ringpu Bio-technology Recent Developments
  13. 8.3 Ruicheng Lvman Biological Pharmaceutical Co., Ltd.
  14. 8.3.1 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolio
  18. 8.3.5 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Merck & Co
  20. 8.4.1 Merck & Co Company Information
  21. 8.4.2 Merck & Co Business Overview
  22. 8.4.3 Merck & Co Veterinary Pain Medication Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck & Co Veterinary Pain Medication Product Portfolio
  24. 8.4.5 Merck & Co Recent Developments
  25. 8.5 Medtronic
  26. 8.5.1 Medtronic Company Information
  27. 8.5.2 Medtronic Business Overview
  28. 8.5.3 Medtronic Veterinary Pain Medication Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Medtronic Veterinary Pain Medication Product Portfolio
  30. 8.5.5 Medtronic Recent Developments
  31. 8.6 Lilly
  32. 8.6.1 Lilly Company Information
  33. 8.6.2 Lilly Business Overview
  34. 8.6.3 Lilly Veterinary Pain Medication Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Lilly Veterinary Pain Medication Product Portfolio
  36. 8.6.5 Lilly Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Veterinary Pain Medication Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Veterinary Pain Medication Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Harbin Bolai Pharmaceutical Co., Ltd.
  44. 8.8.1 Harbin Bolai Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Harbin Bolai Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolio
  48. 8.8.5 Harbin Bolai Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Bostonscientific
  50. 8.9.1 Bostonscientific Company Information
  51. 8.9.2 Bostonscientific Business Overview
  52. 8.9.3 Bostonscientific Veterinary Pain Medication Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Bostonscientific Veterinary Pain Medication Product Portfolio
  54. 8.9.5 Bostonscientific Recent Developments
  55. 8.10 Bayer Pharma AG
  56. 8.10.1 Bayer Pharma AG Company Information
  57. 8.10.2 Bayer Pharma AG Business Overview
  58. 8.10.3 Bayer Pharma AG Veterinary Pain Medication Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Bayer Pharma AG Veterinary Pain Medication Product Portfolio
  60. 8.10.5 Bayer Pharma AG Recent Developments
  61. 8.11 Baxter
  62. 8.11.1 Baxter Company Information
  63. 8.11.2 Baxter Business Overview
  64. 8.11.3 Baxter Veterinary Pain Medication Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Baxter Veterinary Pain Medication Product Portfolio
  66. 8.11.5 Baxter Recent Developments
  67. 8.12 Norbrook Laboratories
  68. 8.12.1 Norbrook Laboratories Company Information
  69. 8.12.2 Norbrook Laboratories Business Overview
  70. 8.12.3 Norbrook Laboratories Veterinary Pain Medication Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Norbrook Laboratories Veterinary Pain Medication Product Portfolio
  72. 8.12.5 Norbrook Laboratories Recent Developments
  73. 8.13 Halyard
  74. 8.13.1 Halyard Company Information
  75. 8.13.2 Halyard Business Overview
  76. 8.13.3 Halyard Veterinary Pain Medication Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Halyard Veterinary Pain Medication Product Portfolio
  78. 8.13.5 Halyard Recent Developments
  79. 8.14 Forest Laboratories
  80. 8.14.1 Forest Laboratories Company Information
  81. 8.14.2 Forest Laboratories Business Overview
  82. 8.14.3 Forest Laboratories Veterinary Pain Medication Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Forest Laboratories Veterinary Pain Medication Product Portfolio
  84. 8.14.5 Forest Laboratories Recent Developments
  85. 8.15 Endo International
  86. 8.15.1 Endo International Company Information
  87. 8.15.2 Endo International Business Overview
  88. 8.15.3 Endo International Veterinary Pain Medication Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Endo International Veterinary Pain Medication Product Portfolio
  90. 8.15.5 Endo International Recent Developments
  91. 8.16 Elanco
  92. 8.16.1 Elanco Company Information
  93. 8.16.2 Elanco Business Overview
  94. 8.16.3 Elanco Veterinary Pain Medication Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Elanco Veterinary Pain Medication Product Portfolio
  96. 8.16.5 Elanco Recent Developments
  97. 8.17 Ceva Sante Animale
  98. 8.17.1 Ceva Sante Animale Company Information
  99. 8.17.2 Ceva Sante Animale Business Overview
  100. 8.17.3 Ceva Sante Animale Veterinary Pain Medication Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Ceva Sante Animale Veterinary Pain Medication Product Portfolio
  102. 8.17.5 Ceva Sante Animale Recent Developments
  103. 8.18 Boehringer Ingelheim
  104. 8.18.1 Boehringer Ingelheim Company Information
  105. 8.18.2 Boehringer Ingelheim Business Overview
  106. 8.18.3 Boehringer Ingelheim Veterinary Pain Medication Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Boehringer Ingelheim Veterinary Pain Medication Product Portfolio
  108. 8.18.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary Pain Medication Value Chain Analysis
  2. 9.1.1 Veterinary Pain Medication Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary Pain Medication Sales Mode & Process
  6. 9.2 Veterinary Pain Medication Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary Pain Medication Distributors
  9. 9.2.3 Veterinary Pain Medication Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst